SEC Form 4 · accession 0001104659-26-084344
Apogee Therapeutics, Inc. · APGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl Dambkowski
Officer — Chief Medical Officer
Period of report
Jul 14, 2026
Accepted (ET)
Jul 16, 2026 · 8:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001974640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 14, 2026 | G | 8,000 | $0.00 | D | 169,873 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund.